93 related articles for article (PubMed ID: 6150328)
1. Ergot for dementia?
Lancet; 1984 Dec; 2(8415):1313-4. PubMed ID: 6150328
[No Abstract] [Full Text] [Related]
2. Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales.
Yesavage JA; Adey M
Adv Biochem Psychopharmacol; 1980; 23():357-62. PubMed ID: 7395622
[No Abstract] [Full Text] [Related]
3. Single-case study of clinical response to high-dose ergot alkaloid treatment for dementia. Preliminary report.
Yesavage JA; Tinklenberg JR
Gerontology; 1981; 27(1-2):76-8. PubMed ID: 7215823
[No Abstract] [Full Text] [Related]
4. Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly.
Gross RJ; Eisdorfer CE; Schiller HS; Cox G
Exp Aging Res; 1979 Aug; 5(4):293-302. PubMed ID: 520386
[TBL] [Abstract][Full Text] [Related]
5. Controlled study of dihydroergotoxine in gerontopsychiatric patients.
Slánská J
Act Nerv Super (Praha); 1989 Apr; 31(1):53-5. PubMed ID: 2782002
[No Abstract] [Full Text] [Related]
6. Review of clinical studies with ergots in gerontology.
Venn RD
Adv Biochem Psychopharmacol; 1980; 23():363-77. PubMed ID: 7395623
[No Abstract] [Full Text] [Related]
7. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
[No Abstract] [Full Text] [Related]
8. Deapril-ST for senile dementia.
Med Lett Drugs Ther; 1977 Jul; 19(15):61-2. PubMed ID: 327247
[No Abstract] [Full Text] [Related]
9. Vasodilators in senile dementia.
Maclay WP
Br Med J; 1979 Oct; 2(6194):866. PubMed ID: 509139
[No Abstract] [Full Text] [Related]
10. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
Matejcek M; Knor K; Piguet PV; Weil C
J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
[TBL] [Abstract][Full Text] [Related]
11. Hydergine helpful for Alzheimer's disease.
Geriatrics; 1979 Oct; 34(10):23. PubMed ID: 478308
[No Abstract] [Full Text] [Related]
12. Ergots in the treatment of mental disorders of old age.
Gaitz CM; Hartford JT
Adv Biochem Psychopharmacol; 1980; 23():349-56. PubMed ID: 7395621
[No Abstract] [Full Text] [Related]
13. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
Yesavage JA; Hollister LE; Burian E
J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
[TBL] [Abstract][Full Text] [Related]
14. Hydergine: a review of 26 clinical studies.
McDonald RJ
Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Ronge J; Dennler HJ
Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
[No Abstract] [Full Text] [Related]
16. Therapeutic possibilities in patients with senile dementia.
Castleden CM
J R Coll Physicians Lond; 1984 Jan; 18(1):28-31. PubMed ID: 6323706
[No Abstract] [Full Text] [Related]
17. Effects of twice standard dosage of neuroactive drugs in dementia. A preliminary report.
Knox J; Hindmarch I; Wallace M
Br J Clin Pract; 1984 Sep; 38(9):313-5. PubMed ID: 6477811
[No Abstract] [Full Text] [Related]
18. The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.
Branconnier RJ
Psychopharmacol Bull; 1983; 19(2):212-9. PubMed ID: 6408682
[No Abstract] [Full Text] [Related]
19. Vasodilators in senile dementia.
Yesavage J
Br Med J; 1979 Nov; 2(6199):1223-4. PubMed ID: 519381
[No Abstract] [Full Text] [Related]
20. Event related evoked potentials in dementia.
Breeze RW
Br J Clin Pract Suppl; 1985 Jun; 39():43-4. PubMed ID: 3929815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
